COST-EFFECTIVENESS ANALYSIS OF LEFLUNOMIDE AS A TREATMENT FOR RHEUMATOID ARTHRITIS IN MEXICO

被引：0
|
作者：
Carlos-Rivera, F. [1 ]
Aguirre-Granados, A. [1 ]
Manterola, S. O. M. C. [2 ]
机构：
[1] RAC Salud Consultores SA CV, Mexico City, DF, Mexico
[2] Econ Salud Sanofi Aventis, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66772-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A537 / A537
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN MEXICO
    Vargas-Valencia, J.
    Sotelo-Guzman, M.
    Mould-Quevedo, J. F.
    Mucino-Ortega, E.
    Galindo-Suarez, R. M.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A127 - A127
  • [2] Cost-Effectiveness of Biosimilars vs Leflunomide in Patients With Rheumatoid Arthritis
    Peng, Kuan
    Chan, Shirley C. W.
    Wang, Yang
    Cheng, Franco W. T.
    Yeung, Winnie W. Y.
    Jiao, Yuanshi
    Chan, Esther W. Y.
    Wong, Ian C. K.
    Lau, Chak-Sing
    Li, Xue
    [J]. JAMA NETWORK OPEN, 2024, 7 (06)
  • [3] COST-EFFECTIVENESS ANALYSIS OF GOLIMUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    Desai, R. J.
    Rao, J.
    Biddle, A. K.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A39 - A39
  • [4] Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UK
    Diamantopoulos, Alex
    Finckh, A.
    Huizinga, T.
    Sungher, D. K.
    Sawyer, L.
    Neto, D.
    Dejonckheere, F.
    [J]. PHARMACOECONOMICS, 2014, 32 (08) : 775 - 787
  • [5] Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UK
    Alex Diamantopoulos
    A. Finckh
    T. Huizinga
    D. K. Sungher
    L. Sawyer
    D. Neto
    F. Dejonckheere
    [J]. PharmacoEconomics, 2014, 32 : 775 - 787
  • [6] COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN PORTUGAL
    Mateus, C.
    Moura, A.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A380 - A381
  • [7] COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN CHINA
    Zhang, Y.
    Yang, L.
    Dong, P.
    Xie, X.
    Tang, B.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A673 - A673
  • [8] Cost-effectiveness of the treatment for early rheumatoid arthritis in Mexico:: Infliximab vs. adalimumab
    Mucino, E.
    Rivas, R.
    Zapata, L.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A259 - A259
  • [9] ABATACEPT FOR THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN ARGENTINA: A COST-EFFECTIVENESS ANALYSIS
    Elgart, J. F.
    Gonzalez, L.
    Aiello, E. C.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A223 - A224
  • [10] COST-EFFECTIVENESS ANALYSIS OF THE TREATMENT OF RHEUMATOID-ARTHRITIS - FEASIBILITY STUDY
    PETTINGILL, BF
    [J]. CLINICAL RESEARCH, 1980, 28 (01): : A149 - A149
12345